<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00473603</url>
  </required_header>
  <id_info>
    <org_study_id>201-05</org_study_id>
    <nct_id>NCT00473603</nct_id>
  </id_info>
  <brief_title>Effect of Free Fatty Acids (FFA) on Androgen Precursors in Women</brief_title>
  <official_title>Effect of Free Fatty Acids on Androgen Precursors in Vivo in Healthy Young Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether free fatty acids modify the androgen levels
      in healthy young women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Free fatty acids (FFA) are known to play an important role by inducing insulin resistance and
      metabolic disturbances in obesity and type 2 diabetes. In addition, FFAs seems to have a
      stimulatory effect on adrenal androgen precursors in men. However, the effect of FFAs on
      androgen precursors and androgens in women is yet unknown.

      Therefore the effect of increased FFAs on adrenal androgens and androgen precursors should be
      investigated in a randomized controlled cross-over trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of DHEA</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of serum DHEA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of DHEAS</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of serum DHEAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of testosterone</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of serum testosterone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change of androstenedione</measure>
    <time_frame>1 day</time_frame>
    <description>Measurement of serum androstenedione</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>urinary androgen excretion</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary cortisol excretion</measure>
    <time_frame>1 day</time_frame>
    <description>measurement of urinary cortisol, aTHF and THF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>urinary cortisone excretion</measure>
    <time_frame>1 day</time_frame>
    <description>measurement of urinary cortisone and THE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in metabolic parameters (e.g. FGF-21)</measure>
    <time_frame>1 day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Hyperandrogenism</condition>
  <condition>Glucocorticoid Metabolism</condition>
  <arm_group>
    <arm_group_label>LHI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>to perform an i.v. lipid heparin infusion for 4 h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>to perform an i.v. saline heparin infusion for 4 h</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lipid/heparin infusion</intervention_name>
    <description>to perform an i.v. lipid heparin infusion infusion for 4 h</description>
    <arm_group_label>LHI</arm_group_label>
    <arm_group_label>SHI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy men and women

        Exclusion Criteria:

          -  diabetes mellitus or impaired glucose tolerance

          -  clinical signs of hyperandrogenism

          -  polycystic ovary

          -  hormonal therapy

          -  BMI &gt; 30 kg/m2

          -  dysmenorrhoea
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Knut Mai, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Charite, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2007</study_first_submitted>
  <study_first_submitted_qc>May 14, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2007</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Professor Joachim Spranger</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>androgens</keyword>
  <keyword>fatty acids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperandrogenism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Androgens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

